Structural basis for the interaction between tankyrase-2 and a potent Wnt-signaling inhibitor.
暂无分享,去创建一个
Natalia Markova | Ida Johansson | Tobias Karlberg | J. Weigelt | Martin Hammarström | Patrick Schütz | H. Schüler | T. Karlberg | N. Markova | I. Johansson | Johan Weigelt | Martin Hammarström | Patrick Schütz | Herwig Schüler | Patrick Schütz
[1] Marc W. Kirschner,et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling , 2009, Nature.
[2] Aled Edwards,et al. In Situ Proteolysis to Generate Crystals for Structure Determination: An Update , 2009, PloS one.
[3] T. Lange,et al. Tankyrase promotes telomere elongation in human cells , 2000, Current Biology.
[4] G. Schulz,et al. Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling. , 1998, Biochemistry.
[5] J. Weigelt,et al. Zinc binding catalytic domain of human tankyrase 1. , 2008, Journal of molecular biology.
[6] Bernhard Lüscher,et al. Toward a unified nomenclature for mammalian ADP-ribosyltransferases. , 2010, Trends in biochemical sciences.
[7] A. Ashworth,et al. Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer , 2009, Oncogene.
[8] A. Ashworth,et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. , 2009, The New England journal of medicine.
[9] S. Kaufmann,et al. PARP inhibition: PARP1 and beyond , 2010, Nature Reviews Cancer.
[10] T. Lange,et al. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. , 1998, Science.
[11] J. Weigelt,et al. Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3. , 2009, Journal of medicinal chemistry.
[12] Martin Hammarström,et al. Crystal structure of the catalytic domain of human PARP2 in complex with PARP inhibitor ABT-888. , 2010, Biochemistry.
[13] G. de Murcia,et al. The PARP superfamily , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.
[14] G. Morin,et al. TANK2, a New TRF1-associated Poly(ADP-ribose) Polymerase, Causes Rapid Induction of Cell Death upon Overexpression* , 2001, The Journal of Biological Chemistry.
[15] A. Ashworth,et al. DNA repair deficiency as a therapeutic target in cancer. , 2008, Current opinion in genetics & development.